Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 mars 2026 12h37 HE | Source: Research and Markets

Roferon-a (F. Hoffmann-La Roche) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Roferon-a Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
13 mars 2026 07h46 HE | Source: Research and Markets

Tezspire (AstraZeneca, Amgen) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Tezspire Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
13 mars 2026 07h39 HE | Source: Research and Markets

Rixubis (Takeda Pharmaceutical) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Rixubis Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
12 mars 2026 11h42 HE | Source: Research and Markets

Pharmaceuticals and Biotechnology Option and Evaluation Agreements Report 2026 with Directory of Deals Signed Since 2019 by Company A-Z, Therapeutic Area, Technology Type, and Industry Sector

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering.The Option and...
12 mars 2026 11h39 HE | Source: Research and Markets

Pharmaceuticals Collaboration Agreement Report 2026 with Directory of Deals Signed Since 2020

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Pharmaceuticals 2020-2026" report has been added to ResearchAndMarkets.com's offering.The Collaboration Deals in...
10 mars 2026 08h23 HE | Source: Research and Markets

Esperoct (Novo Nordisk) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Esperoct Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
10 mars 2026 05h21 HE | Source: Research and Markets

Rebyota (Ferring Pharmaceuticals) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Rebyota Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
09 mars 2026 12h19 HE | Source: Research and Markets

Ixiaro (Valneva) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Ixiaro Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
09 mars 2026 12h10 HE | Source: Research and Markets

Jetrea (Oxurion) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Jetrea Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
24 févr. 2026 08h30 HE | Source: Shorepower Technologies Inc.

Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform

Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC

Page suivante